Cytokinetics Correlations
| CYTK Stock | USD 66.26 1.22 1.88% |
The current 90-days correlation between Cytokinetics and Nuvalent is 0.3 (i.e., Weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cytokinetics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cytokinetics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Cytokinetics Correlation With Market
Very good diversification
The correlation between Cytokinetics and DJI is -0.24 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cytokinetics and DJI in the same portfolio, assuming nothing else is changed.
Cytokinetics | Build AI portfolio with Cytokinetics Stock |
Moving against Cytokinetics Stock
| 0.54 | DXB | Dimerix | PairCorr |
| 0.52 | VERA | Vera Therapeutics Sell-off Trend | PairCorr |
| 0.45 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.49 | HDP1 | Arrowhead Pharmaceuticals | PairCorr |
| 0.43 | VNDA | Vanda Pharmaceuticals | PairCorr |
| 0.38 | NP5 | NEWRON PHARMACEUT | PairCorr |
| 0.38 | VTVT | vTv Therapeutics | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Cytokinetics Stock performing well and Cytokinetics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cytokinetics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| NUVL | 2.12 | 0.15 | 0.04 | 0.83 | 2.40 | 3.45 | 17.72 | |||
| ABVX | 3.19 | 0.33 | 0.07 | 3.44 | 3.39 | 6.94 | 29.38 | |||
| AXSM | 1.84 | 0.47 | 0.23 | (3.11) | 1.38 | 4.20 | 26.78 | |||
| RYTM | 2.38 | (0.02) | (0.01) | 0.04 | 2.82 | 4.76 | 18.69 | |||
| HALO | 1.66 | 0.20 | 0.09 | 0.32 | 1.78 | 3.72 | 9.83 | |||
| MTSR | 4.01 | 1.66 | 0.46 | (1.26) | 2.40 | 14.25 | 75.60 | |||
| JAZZ | 1.63 | 0.41 | 0.16 | (0.64) | 1.53 | 3.66 | 25.96 | |||
| CORT | 3.65 | (0.75) | 0.00 | (0.22) | 0.00 | 6.44 | 55.08 | |||
| CRSP | 2.78 | (0.09) | (0.01) | 0.01 | 3.34 | 6.23 | 19.81 |
Cytokinetics Corporate Management
| Jennifer MBA | VP Marketing | Profile | |
| Holly Laughlin | VP Controller | Profile | |
| Jeff Lotz | Vice Operations | Profile | |
| Laura MD | Medical Clinical | Profile | |
| Scott Jordan | Senior Strategy | Profile | |
| FACC MD | Ex RD | Profile | |
| Eric Terhaerdt | Senior Operations | Profile |